INCY vs XLO · P/E 14, rev $5.14B vs rev $31.3M
Incyte Corporation (INCY) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. XLO currently screens at market cap $55.3M.
Not investment advice. Open the INCY and XLO stock pages for the full models.
Not investment advice.